Nuzenio

Knight Therapeutics Reports

Knight Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Knight Therapeutics (TSX:GUD) Stock Revenue Strength Clashes With Lingering Losses - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:12:18 GMTThe Bull Case For Cullinan Therapeutics (CGEM) Could Change Following FDA-Backed Phase 2 CLN-049 Trial - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 12:16:05 GMTKnight Therapeutics Inc (KHTRF) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:15:22 GMTKnight Therapeutics Q2 2026 Earnings Call Transcript - MarketBeatMarketBeat · Thu, 06 Aug 2026 17:40:27 GMTKnight Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:42:32 GMTEarnings Flash (GUD.TO) Knight Therapeutics Reports Q2 Revenue C$144.2M, vs. FactSet Est of C$126.4M - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:05:42 GMTKnight Therapeutics Reports Second Quarter 2026 Results - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 10:30:00 GMTIs Knight Therapeutics (TSX:GUD) Redefining Canada’s Specialty Pharma Landscape? - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 21:20:00 GMT

Timeline

Sat, 08 Aug 2026 01:12:18 GMTKnight Therapeutics (TSX:GUD) Stock Revenue Strength Clashes With Lingering Losses - simplywall.st
Fri, 07 Aug 2026 12:16:05 GMTThe Bull Case For Cullinan Therapeutics (CGEM) Could Change Following FDA-Backed Phase 2 CLN-049 Trial - Yahoo! Finance Canada
Thu, 06 Aug 2026 23:15:22 GMTKnight Therapeutics Inc (KHTRF) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance
Thu, 06 Aug 2026 17:40:27 GMTKnight Therapeutics Q2 2026 Earnings Call Transcript - MarketBeat
Thu, 06 Aug 2026 12:42:32 GMTKnight Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Thu, 06 Aug 2026 12:05:42 GMTEarnings Flash (GUD.TO) Knight Therapeutics Reports Q2 Revenue C$144.2M, vs. FactSet Est of C$126.4M - marketscreener.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Knight Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.